Values First Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History

Values First Advisors, Inc.

$166 Million
Q1 2025

A detailed history of Values First Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Values First Advisors, Inc. holds 16,645 shares of COLL stock, worth $481,206. This represents 0.3% of its overall portfolio holdings.

Number of Shares

16,645

Previous 16,906 1.54%

Holding current value

$481,206

Previous $484,000 2.48%

% of portfolio

0.3%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$28.04 - $33.91 $7,318 - $8,850	-261 Reduced 1.54%	16,645 $496,000
Q4 2024 Jan 29, 2025	SELL	$28.61 - $41.86 $43,086 - $63,041	-1,506 Reduced 8.18%	16,906 $484,000
Q3 2024 Oct 23, 2024	BUY	$31.4 - $39.07 $44,556 - $55,440	1,419 Added 8.35%	18,412 $711,000
Q2 2024 Jul 19, 2024	BUY	$31.36 - $39.99 $33,147 - $42,269	1,057 Added 6.63%	16,993 $547,000
Q1 2024 Apr 23, 2024	SELL	$31.23 - $40.91 $559,922 - $733,475	-17,929 Reduced 52.94%	15,936 $618,000
Q4 2023 Jan 18, 2024	SELL	$21.16 - $30.8 $204,024 - $296,973	-9,642 Reduced 22.16%	33,865 $1.04 Million
Q3 2023 Nov 08, 2023	BUY	$21.23 - $24.28 $139,205 - $159,203	6,557 Added 17.75%	43,507 $972,000
Q2 2023 Aug 02, 2023	BUY	$21.06 - $24.0 $154,264 - $175,800	7,325 Added 24.73%	36,950 $794,000
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $414,069 - $537,929	-18,003 Reduced 37.8%	29,625 $710,000
Q4 2022 Jan 20, 2023	BUY	$16.14 - $23.55 $35,395 - $51,645	2,193 Added 4.83%	47,628 $0
Q3 2022 Dec 02, 2022	SELL	$15.46 - $20.1 $40,999 - $53,305	-2,652 Reduced 5.52%	45,435 $728,000
Q2 2022 Jul 20, 2022	BUY	$14.22 - $20.88 $35,180 - $51,657	2,474 Added 5.42%	48,087 $852,000
Q1 2022 May 03, 2022	BUY	$17.2 - $22.5 $56,777 - $74,272	3,301 Added 7.8%	45,613 $929,000
Q4 2021 Mar 10, 2022	BUY	$17.5 - $21.35 $740,460 - $903,361	42,312 New	42,312 $790,000
Q3 2021 Nov 15, 2022	SELL	$17.75 - $25.39 $112,073 - $160,312	-6,314 Reduced 13.13%	41,773 $825,000
Q2 2021 Nov 15, 2022	BUY	$21.74 - $25.28 $94,025 - $109,336	4,325 Added 13.15%	37,222 $880,000
Q1 2021 Nov 15, 2022	SELL	$19.25 - $26.1 $292,407 - $396,459	-15,190 Reduced 31.59%	32,897 $780,000
Q4 2020 Nov 15, 2022	BUY	$17.83 - $22.29 $139,038 - $173,817	7,798 Added 24.96%	39,039 $782,000
Q3 2020 Nov 15, 2022	BUY	$15.78 - $20.82 $109,386 - $144,324	6,932 Added 28.52%	31,241 $650,000
Q2 2020 Nov 15, 2022	SELL	$15.49 - $23.51 $236,842 - $359,467	-15,290 Reduced 38.61%	24,309 $425,000
Q1 2020 Jan 09, 2023	SELL	$13.89 - $25.45 $292,940 - $536,740	-21,090 Reduced 46.42%	24,345 $398 Million
Q4 2019 Nov 15, 2022	SELL	$10.7 - $22.24 $90,821 - $188,773	-8,488 Reduced 17.65%	39,599 $815,000

Others Institutions Holding COLL

# of Institutions

254

Shares Held

37.2M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $987M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Account

Values First Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History